Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy

Ioannis Bougioukas1, Uta Hoppe2, Bernhard Danner1

  • 1Department of Thoracic and Cardiovascular Surgery, Georg-Agust University, Goettingen, Germany.

Insights

Hypertrophic cardiomyopathy (HCM) treatment can be complex. This case highlights successful surgical myectomy for recurrent obstruction after alcohol septal ablation, addressing unique anatomical challenges.

Area of Science:

  • Cardiology
  • Genetics
  • Cardiac Surgery

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease causing left ventricular hypertrophy.
  • Left ventricular outflow tract obstruction in HCM, refractory to medication, requires surgical myectomy or alcohol septal ablation.
  • Recurrence of obstruction can necessitate further intervention.

Purpose of the Study:

  • To report a unique case of recurrent hypertrophic cardiomyopathy obstruction after alcohol septal ablation.
  • To describe the surgical management of complex anatomical findings contributing to obstruction.
  • To evaluate the efficacy of surgical myectomy in achieving relief of obstruction.

Main Methods:

  • Surgical myectomy was performed for recurrent left ventricular outflow tract obstruction.
  • Extensive papillary muscle mobilization was a key surgical technique.
  • Pre-operative and post-operative assessments evaluated the degree of obstruction.

Main Results:

  • The patient presented with obstruction recurrence one year after alcohol septal ablation.
  • Intraoperative findings included a firm subaortic membrane and direct papillary muscle insertion into the mitral valve.
  • Significant relief of left ventricular outflow tract obstruction was achieved post-myectomy and papillary muscle mobilization.

Conclusions:

  • Surgical myectomy can be effective in managing recurrent obstruction in hypertrophic cardiomyopathy.
  • Addressing specific anatomical abnormalities, such as subaortic membranes and abnormal papillary muscle insertions, is crucial for successful surgical outcomes.
  • This case underscores the importance of tailored surgical approaches for complex hypertrophic cardiomyopathy cases.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
702
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
399